Back to search

Article

Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteres

2026-01-23

Abstract excerpt

<h4> A bstract </h4> Vaccines comprising peptide antigens for inducing T cell immunity are being developed for a broad range of therapeutic applications including prevention and treatment of cancer, autoimmunity, and infectious diseases. However, many peptide antigens contain cysteine and/or methionine, which are prone to form oxidation products that can present challenges to manufacturing and reduce biological...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
261bcdd0-f1a5-5039-a772-2847d29dd136
DOI
10.64898/2026.01.20.699901
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteresDOI 10.64898/2026.01.20.699901
Select a neighboring publication to make it the new centre.